drugset / Trial / NCT05203354

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

NCT05203354

Phase 4 Completed 60 enrolled Mahmoud Ahmed Ali Ahmed
RandomizedParallel-groupDouble-blindTreatment

Summary

Studying the effects of Narrowband Ultraviolet B versus acitretin on psoriatic patients

Timeline

Start
2018-09-01
Primary completion
2021-05-01
Completion
2021-08-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acitretin Small molecule 0.5 mg/kg
Comparator Acitretin Small molecule 1 mg/kg

Indications